CLINICAL SIGNIFICANCE OF ADIPOSE TISSUE INVASION IN ER-POSITIVE BREAST CANCER

被引:1
|
作者
Liu, Qi [1 ]
Sun, Zheng [1 ]
Li, Long-Long [1 ]
Fu, Zheng-Peng [2 ]
Xu, Chun-Hong [1 ]
机构
[1] Weifang Tradit Chinese Hosp, Dept Breast & Thyroid Surg, Weifang, Shandong, Peoples R China
[2] Weifang Tradit Chinese Hosp, Dept Pathol, Weifang, Shandong, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2022年 / 38卷 / 05期
关键词
Adipose tissue invasion; Breast cancer; Molecular subtype; Estrogen receptor; Prognosis;
D O I
10.19193/0393-6384_2022_5_499
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study is to investigate the prognostic significance of adipose tissue invasion in breast cancer patients and its potential value for breast cancer therapy. Methods: A total of 162 patients with early breast cancer were selected from June 2014 to June 2015 in Department of Breast and Thyroid Surgery of Weifang Hospital of Traditional Chinese Medicine. The clinical data of the patients were collected, and the relationship between adipose tissue invasion and clinicopathological factors was analyzed. Results: Among the 162 patients, there were 56 cases of breast cancer patients with adipose tissue invasion and 106 cases without adipose tissue invasion. Univariate analysis showed that tumor histological grade (P=0.041), tumor size (P=0.029), lymph node metastasis (P=0.032), positive ER (P=0.001) and molecular subtype (P=0.01) were related to adipose tissue invasion. In addition, Luminal B was positively correlated with the adipose tissue invasion, while TNBC was negatively correlated with the adipose tissue invasion. Logistic regression analysis showed that tumor histological grade (P=0.014), lymph node metastasis (P=0.003), and positive ER (P=0.044) were significantly correlated with adipose tissue invasion. Patients with adipose tissue invasion (24/ 56, 42.85%) had a worse prognosis than those without adipose tissue invasion (26/ 106, 24.58%) at 5-year follow-up (P=0.004). Conclusion: In this study, histological grade, lymph node metastasis and positive ER were found to be associated with adipose tissue invasion of breast cancer, suggesting that adipose tissue invasion is associated with low prognosis of breast cancer and may affect the treatment of ER- positive breast cancer patients.
引用
收藏
页码:3383 / 3387
页数:5
相关论文
共 50 条
  • [21] Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer
    Ditzel, Henrik J.
    Lyng, Maria B.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (07): : 376 - 377
  • [22] Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer
    Henrik J Ditzel
    Maria B Lyng
    Nature Clinical Practice Oncology, 2008, 5 : 376 - 377
  • [23] Clinical relevance of miR-143 expression in ER-positive breast cancer patients.
    Tokumaru, Yoshihisa
    Oshi, Masanori
    Katsuta, Eriko
    Matsuhashi, Nobuhisa
    Futamura, Manabu
    Yoshida, Kazuhiro
    Takabe, Kazuaki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] The clinical significance of circulating DSCAM-AS1 in patients with ER-positive breast cancer and construction of its competitive endogenous RNA network
    Mohammad-Taher Moradi
    Hossein Fallahi
    Zohreh Rahimi
    Molecular Biology Reports, 2020, 47 : 7685 - 7697
  • [25] Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy
    Kim, Tae-Jung
    Lee, Ahwon
    Choi, Yeong-Jin
    Song, Byung Joo
    Yim, Hyeon Woo
    Kang, Chang Suk
    JOURNAL OF BREAST CANCER, 2012, 15 (01) : 79 - 86
  • [26] The clinical significance of circulating DSCAM-AS1 in patients with ER-positive breast cancer and construction of its competitive endogenous RNA network
    Moradi, Mohammad-Taher
    Fallahi, Hossein
    Rahimi, Zohreh
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (10) : 7685 - 7697
  • [27] An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
    Zhou, Xin
    Wang, Xiaping
    Huang, Zebo
    Xu, Lei
    Zhu, Wei
    Liu, Ping
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
  • [28] AgNOR analysis of ER-positive and ER-negative tumor cells in breast cancer
    Guski, E
    Winzer, KJ
    Hufnagl, P
    Günther, L
    Kaufmann, O
    PROCEEDINGS OF THE GERMAN SOCIETY FOR PATHOLOGY 82ND MEETING - 1998: SOFT TISSUE TUMORS, 1998, : 470 - 470
  • [29] AgNOR analysis of ER-positive and ER-negative cells in breast cancer.
    Guski, H
    Winzer, KJ
    Hufnagl, P
    Gunther, L
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1996, 40 (04): : 341 - 341
  • [30] Exemestane: One part of the chemopreventive spectrum for ER-positive breast cancer
    Dunn, Barbara K.
    Cazzaniga, Massimiliano
    DeCensi, Andrea
    BREAST, 2013, 22 (03): : 225 - 237